查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1766331

DNA 取证市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

DNA Forensics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 132 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024年，全球DNA取证市场规模达35亿美元，预计2034年将以5.4%的复合年增长率成长，达到62亿美元。这一稳步增长的动力源于法律和刑事调查领域对精准识别方法和先进分析工具日益增长的需求。随着全球犯罪率持续上升，精准DNA分析在现代司法体系中的重要性日益凸显。法医DNA检测之所以被广泛采用，很大程度上归功于其在将证据与嫌疑人关联方面的可靠性，以及其能够以高可信度支持法律诉讼的能力。

DNA 取证市场 - IMG1

此外，法医实验室整合先进技术正在简化分析流程，帮助当局更有效率地处理复杂的刑事案件。多个地区的政府正在积极支持法医实验室，为其提供资金和基础设施升级，这进一步加速了DNA法医在刑事司法系统中的应用。同时，私部门参与者正专注于创新，并透过策略联盟、合作伙伴关係和研发计划拓展其在尚未开发的市场的影响力。这些共同努力正在为未来十年的持续市场成长奠定坚实的基础。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 35亿美元
预测值 62亿美元
复合年增长率 5.4%

DNA法医领域的领先公司正大力投资新产品开发，以跟上技术进步和不断发展的法医标准。一个关键趋势是转向更便携、更高速的DNA分析设备，这些设备能够在不影响准确性的情况下提高效率。除了推出新产品外，各公司还在新兴经济体拓展业务，旨在吸引新的客户群并提高法医工具的可及性。生技公司与公共机构之间的合作也促进了市场扩张，促进了技术知识的交流，并简化了将新技术融入常规法医工作流程的流程。这些策略将为该产业在未来几年的持续发展和竞争差异化奠定基础。

根据解决方案，软体细分市场包括实验室资讯管理系统 (LIMS) 和其他法医软体工具。其中，耗材细分市场占据主导地位，2024 年的营收份额最高，达 37.7%。耗材需求的成长与 DNA 分析技术的进步直接相关，这些技术需要持续使用高品质的材料进行样品製备和检测。随着各行各业对 DNA 分析的依赖程度不断提高，试剂、萃取工具和分析配件的消耗量持续激增，推动了该细分市场的持续成长。

市场也按方法细分，包括毛细管电泳 (CE)、PCR 扩增、新一代定序 (NGS) 和其他技术。毛细管电泳占据领先地位，2024 年的收入达到 12 亿美元。 CE 以其高解析度能力而闻名，即使在降解样本中也能精确分离和分析 DNA 片段，因此在法医实验室中被广泛采用。其可靠性和速度使其成为高通量法医工作流程的理想选择，尤其是在需要快速週转以解决时间紧迫的案件时。

依应用领域划分，市场分为刑事鑑定、亲子鑑定和家族鑑定。刑事鑑定是最大的细分市场，2024年的收入达到20亿美元。刑事调查的日益复杂化以及对可靠DNA证据的日益重视，推动了这一细分市场的发展。随着基因检测在执法工作中变得越来越重要，对能够有效识别和验证嫌疑人的技术的需求持续增长。 DNA资料库和调查工具的广泛应用也扩大了各司法管辖区对DNA法医的需求。

从地区来看，北美占据全球市场主导地位，2024年占总营收的42.1%以上。该地区的领先地位得益于DNA检测技术的快速发展、公共和私营部门对法医基础设施的大力投资，以及对提高法律结果准确性的日益重视。在北美，美国仍是主要贡献者，预计到2034年市场价值将达到24亿美元。在旨在实现法医系统现代化的有利政策框架和倡议的支持下，美国各州和联邦犯罪实验室都在越来越多地部署法医技术。

竞争格局以包括Illumina、QIAGEN、Thermo Fisher Scientific、Promega和Danaher在内的全球主要企业为标誌，这些企业合计占据了超过50%的市场份额。这些公司积极致力于开发下一代法医工具，包括快速DNA技术、家谱追踪资料库和紧凑型检测系统。对研发的策略性投资、与研究机构的合作以及拓展新市场是其成长策略的核心。监管简化和审批流程的缩短也使得企业能够更快进入市场，从而满足全球对可靠法医解决方案日益增长的需求。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 政府为法医计画提供的措施和资金
      • 亲子鑑定与家族鑑定的技术进步
      • 犯罪活动增多
    • 产业陷阱与挑战
      • 设备成本高
      • 发展中国家缺乏熟练的专业人员
    • 市场机会
      • 在采集点采用快速 DNA 技术
      • 人工智慧和机器学习在 DNA资料解读中的日益融合
  • 成长潜力分析
  • 监管格局
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 技术格局
    • 当前的技术趋势
    • 新兴技术
  • 定价分析
  • 未来市场趋势
  • 差距分析
  • 专利分析
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板
  • 关键进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估计与预测：按解决方案，2021 - 2034 年

  • 主要趋势
  • 套件
  • 分析仪和定序仪
  • 软体
    • 实验室资讯管理系统
    • 其他软体类型
  • 耗材

第六章：市场估计与预测：依方法，2021 - 2034 年

  • 主要趋势
  • 毛细管电泳（CE）
  • 下一代定序（NGS）
  • PCR扩增
  • 其他方法

第七章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 刑事测试
  • 亲子鑑定和家族史检测

第八章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋

第九章：公司简介

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Danaher
  • GORDIZ
  • Illumina
  • Laboratory Corporation of America Holdings
  • LabVantage Solution
  • LabWare
  • Promega
  • Qiagen
  • Thermo Fisher Scientific
  • VERISIS
简介目录
Product Code: 5160

The Global DNA Forensics Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 5.4% to reach USD 6.2 billion by 2034. This steady expansion is driven by a growing need for precise identification methods and advanced analytical tools in legal and criminal investigations. As crime rates continue to rise globally, the demand for accurate DNA profiling is becoming increasingly vital in modern judicial systems. The widespread adoption of forensic DNA testing is largely attributed to its reliability in linking evidence to suspects, as well as its ability to support legal proceedings with high credibility.

DNA Forensics Market - IMG1

Furthermore, the integration of advanced technologies in forensic labs is streamlining the analysis process and helping authorities address complex criminal cases more efficiently. Governments across multiple regions are actively supporting forensic labs with funding and infrastructure upgrades, which is further accelerating the use of DNA forensics in criminal justice systems. Meanwhile, private sector players are focusing on innovation and expanding their reach across untapped markets through strategic alliances, partnerships, and research and development initiatives. These collective efforts are creating a robust foundation for consistent market growth over the next decade.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$3.5 Billion
Forecast Value$6.2 Billion
CAGR5.4%

Leading companies in the DNA forensics space are investing heavily in new product development to keep pace with technological advancements and evolving forensic standards. A key trend is the shift toward more portable, high-speed DNA analysis devices that enhance efficiency without compromising accuracy. In addition to new product launches, players are expanding their operational footprints in emerging economies, aiming to capture new customer bases and improve accessibility to forensic tools. Collaborations between biotech firms and public institutions are also contributing to market expansion by fostering the exchange of technical knowledge and streamlining the integration of newer technologies into routine forensic workflows. These strategies are positioning the industry for continued advancement and competitive differentiation in the years ahead.

Based on solution, the software segment includes LIMS and other forensic software tools. Among these, the consumables segment emerged as the dominant category, accounting for the largest revenue share of 37.7% in 2024. The rising demand for consumables is directly linked to advancements in DNA analysis techniques that require consistent use of high-quality materials for sample preparation and examination. As the reliance on DNA profiling increases across sectors, the consumption of reagents, extraction tools, and analysis accessories continues to surge, driving segment growth.

The market is also segmented by method, including capillary electrophoresis (CE), PCR amplification, next-generation sequencing (NGS), and other techniques. Capillary electrophoresis held the leading position, generating a revenue of USD 1.2 billion in 2024. Known for its high-resolution capabilities, CE is widely adopted in forensic labs due to its precision in separating and analyzing DNA fragments, even in degraded samples. Its reliability and speed make it an ideal choice for high-throughput forensic workflows, especially when quick turnarounds are essential for solving time-sensitive cases.

By application, the market is divided into criminal testing and paternity and familial testing. Criminal testing represented the largest segment, with a revenue of USD 2 billion in 2024. The increasing sophistication of criminal investigations and the growing emphasis on reliable DNA evidence are pushing this segment forward. With genetic testing becoming more integral to law enforcement, demand continues to grow for technologies that enable efficient identification and suspect verification. The expanding use of DNA databases and investigative tools is also amplifying the need for DNA forensics across jurisdictions.

Regionally, North America dominated the global market, accounting for more than 42.1% of total revenue in 2024. The region's leadership is fueled by rapid advancements in DNA testing technologies, strong public and private investments in forensic infrastructure, and a growing emphasis on improving the accuracy of legal outcomes. Within North America, the United States remains the key contributor and is forecast to reach a market value of USD 2.4 billion by 2034. The U.S. is witnessing increased deployment of forensic technologies across both state and federal crime labs, supported by favorable policy frameworks and initiatives aimed at modernizing forensic systems.

The competitive landscape is marked by the presence of major global players, including Illumina, QIAGEN, Thermo Fisher Scientific, Promega, and Danaher, which collectively contribute to more than 50% of the total market share. These companies are actively engaged in the development of next-generation forensic tools, including rapid DNA technologies, genealogical tracing databases, and compact testing systems. Strategic investments in R&D, partnerships with research institutes, and expansion into new markets are central to their growth strategies. Regulatory streamlining and quicker approval timelines are also enabling faster market entry, allowing companies to meet the growing demand for reliable forensic solutions globally.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 Synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Solution
    • 2.2.3 Method
    • 2.2.4 Application
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Government initiatives and funds for forensic programs
      • 3.2.1.2 Technological advancements in paternity and familial testing
      • 3.2.1.3 Increasing criminal activities
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of equipment
      • 3.2.2.2 Dearth of skilled professional in developing countries
    • 3.2.3 Market opportunities
      • 3.2.3.1 Adoption of rapid DNA technologies at point-of-collection
      • 3.2.3.2 Growing integration of AI and machine learning in DNA data interpretation
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Pricing analysis
  • 3.7 Future market trends
  • 3.8 Gap analysis
  • 3.9 Patent analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard
  • 4.7 Key developments
    • 4.7.1 Mergers & acquisitions
    • 4.7.2 Partnerships & collaborations
    • 4.7.3 New product launches
    • 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Solution, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Kits
  • 5.3 Analyzers and sequencers
  • 5.4 Software
    • 5.4.1 LIMS
    • 5.4.2 Other software types
  • 5.5 Consumables

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capillary electrophoresis (CE)
  • 6.3 Next generation sequencing (NGS)
  • 6.4 PCR amplification
  • 6.5 Other methods

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Criminal testing
  • 7.3 Paternity and familial testing

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Bio-Rad Laboratories
  • 9.3 Danaher
  • 9.4 GORDIZ
  • 9.5 Illumina
  • 9.6 Laboratory Corporation of America Holdings
  • 9.7 LabVantage Solution
  • 9.8 LabWare
  • 9.9 Promega
  • 9.10 Qiagen
  • 9.11 Thermo Fisher Scientific
  • 9.12 VERISIS